Essakalli M, Atouf O, Bennani N, Benseffaj N, Ouadghiri S, Brick C
Service de transfusion et d'hémovigilance, hôpital Ibn-Sina, CHU de Rabat, B.P. 2014, Rabat-Ryad, 10000 Rabat, Maroc.
Pathol Biol (Paris). 2009 Jul;57(5):430-8. doi: 10.1016/j.patbio.2008.04.003. Epub 2008 May 29.
The toll-like receptors are innate immunity receptors which recognise particular exogenous structures in the microorganisms pathogen associated molecular pattern (PAMP) and endogenous structures damage-associated molecular patterns (DAMP). Eleven TLR have been identified among human beings. These are danger receptors located in the cells of the immune system but also in other cells. Their primary function is the recognition of pathogens and the activation of the cell that holds them. It follows from it an action on the cells environment, inflammation cells and an activation of the adaptive immunity. The knowledge of the intracellular signalisation ways of the TLR has allowed us to understand the physiopathology of certain diseases. Thus, several works use the agonists of TLR to stimulate them: vaccines against infectious diseases, allergies and cancers. The antagonists are used to block the TLR in autoimmune and chronic inflammatory diseases. It is clear that the border between innate and adaptive immunity fades and that these two components of the immune response are closely related, thus opening up new prospects diagnostic and therapeutic procedures.
Toll样受体是先天性免疫受体,可识别微生物病原体相关分子模式(PAMP)中的特定外源结构以及内源性结构损伤相关分子模式(DAMP)。已在人类中鉴定出11种Toll样受体。这些是位于免疫系统细胞以及其他细胞中的危险受体。它们的主要功能是识别病原体并激活携带病原体的细胞。由此对细胞环境、炎症细胞产生作用,并激活适应性免疫。对Toll样受体内在信号传导途径的了解使我们能够理解某些疾病的生理病理学。因此,一些研究使用Toll样受体激动剂来刺激它们:用于预防传染病、过敏和癌症的疫苗。拮抗剂则用于在自身免疫性疾病和慢性炎症性疾病中阻断Toll样受体。显然,先天性免疫和适应性免疫之间的界限正在消失,并且免疫反应的这两个组成部分密切相关,从而为诊断和治疗程序开辟了新的前景。